J DRUGS DERMATOL - Journal of Drugs in Dermatology
Publikationen
- 2022
Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab
Augustin, M., Gallo, G., See, K., McKean-Matthews, M., Burge, R., Gooderham, M. & Reich, K., 01.02.2022, in: J DRUGS DERMATOL. 21, 2, S. 122-126 5 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
- 2018
Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis
Pincelli, C., Schafer, P. H., French, L. E., Augustin, M. & Krueger, J. G., 01.08.2018, in: J DRUGS DERMATOL. 17, 8, S. 835-840 6 S.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
- 2012
PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.
Papp, K. A., Strober, B., Augustin, M., Calabro, S., Londhe, A., Chevrier, M., Investigators, PSOLAR. & Committee, S., 2012, in: J DRUGS DERMATOL. 11, 10, S. 1210-1217 10.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
